Trump, CMPS and Compass Pathways
Digest more
A White House Executive Order over the weekend has some healthcare company stocks soaring today. One big winner is Compass Pathways (NASDAQ: CMPS). Shares of the biotechnology company rocketed more than 50% this morning and were still higher by 41.2% at noon ET.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Before we talk about Rocket and Compass, we need to talk about OriginPoint. In 2021, Compass and then Guaranteed Rate (now Rate) announced the formation of OriginPoint, a joint venture mortgage company designed to embed origination directly inside the Compass agent network.
The Consumer Policy Center estimated that Compass’ market share was up to 40 percent after its deal for Anywhere Real Estate.
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for a grant to create training content for healthcare providers to deliver investigational COMP360 psilocybin treatment,